Justin Verlander loses no-hit bid in the ninth, settles for complete game shutout

8 Comments

UPDATE: So much for that. Justin Verlander’s no-hit bid was broken up on a single by Josh Harrison with one out in the ninth. Harrison just stuck his bat out and the ball just managed to eek past the outstretched glove of shortstop Jhonny Peralta.

Verlander was given a rousing ovation by the Comerica Park crowd for his efforts before settling down to get Neil Walker and Andrew McCutchen on ground outs to end it. He ended up settling for a complete game one-hitter as part of a 6-0 victory. The Detroit ace is now 5-1 on the year with a 2.14 ERA and 68/14 K/BB ratio over 67 1/3 innings.

9:13 PM: The no-no is still intact after Verlander struck out out the side in a dominant eighth inning. He got Casey McGehee looking and Nate McLouth and Clint Barmes swinging, giving him 12 strikeouts on the night. He’s still bringing high-90s heat consistently and even hit 100 mph in the inning according to the TV gun. Absurd.

He’s slated to face Michael McKenry, Josh Harrison and Neil Walker in the ninth.

8:59 PM: We could be witnessing a little bit of history tonight in Detroit.

Justin Verlander, who already has two career no-hitters, has yet to allow a hit over his first seven innings of work against the Pirates.

Verlander has issued two walks on the night, including Neil Walker in the first and Andrew McCutchen in the seventh. He has nine strikeouts, including a nasty breaking ball that which caught Garrett Jones looking to end the seventh and stranded McCutchen at second base. His pitch count is at 82, so he’s probably going the distance in this thing no matter what. The Tigers currently have a 4-0 lead.

Verlander is slated to face Casey McGehee, Nate McLouth and Clint Barmes in the eighth. If he can complete the feat, he’ll join Cy Young, Bob Feller and Larry Corcoran with three career no-hitters. Sandy Koufax had four and Nolan Ryan had seven.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.